Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
Precise dosing of warfarin is important to achieve therapeutic benefit without adverse effects. Pharmacogenomics explains some interindividual variability in warfarin response, but less attention has been paid to drug‐drug interactions in the context of genetic factors. We investigated retrospective...
Saved in:
Main Authors: | Saaket Agrawal (Author), Meredith S. Heiss (Author), Remington B. Fenter (Author), Tatiana V. Abramova (Author), Minoli A. Perera (Author), Jennifer A. Pacheco (Author), Maureen E. Smith (Author), Laura J. Rasmussen‐Torvik (Author), Alfred L. George Jr (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ethnic Diversity and Warfarin Pharmacogenomics
by: Innocent G. Asiimwe, et al.
Published: (2022) -
Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
by: Jia LQ, et al.
Published: (2017) -
VKORC1, CYP2C9 Polymorphisms and clotting factors associated with warfarin maintenance dose
by: Alisara Sangviroon
Published: (2014) -
PK/PD of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in indonesian patients
by: Taofik Rusdiana, et al.
Published: (2012) -
The effect of CYP2C9*2, CYP2C9*3, and VKORC1-1639 G>A polymorphism in patients under warfarin therapy in city of Kermanshah
by: Zohreh Hosseinkhani, et al.
Published: (2018)